The American Medical Association pledged its full support for legislation repealing the Medicare sustainable growth-rate physician payment formula.
The American Medical Association pledged its full support for legislation repealing the Medicare sustainable growth-rate physician payment formula. But for now, at least, the AMA is not making any suggestions on how to cover the bill's estimated $126 billion cost.
“Congress can manage this,” Dr. Ardis Dee Hoven, AMA president, told reporters during a conference call.
She added that the AMA is adamantly opposed to a nine-month suspension of SGR-driven pay cuts that some lawmakers proposed, including in a bill to raise the national debt ceiling. Doctors will receive a 24% Medicare pay cut if Congress doesn't act by March 31.
Read the full story here: http://bit.ly/MKZZNO
Source: Modern Healthcare
Trump Administration’s Message to Supreme Court Puts New Wrinkle in Braidwood Case
February 21st 2025The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
Same-Day Breast Imaging Gaps Reveal Health Care Disparities
February 18th 2025For this retrospective study, the authors examined data on more than 3 million screening mammographies for more than 1 million female patients; of the screenings, 23.6% had abnormal results and only 6.7% were recommended for biopsy.
Read More